FDA Drug Safety Podcast: FDA to review study examining use of oral fluconazole (Diflucan) in pregnancy

On April 26, 2016 FDA announced that it is evaluating the results of a Danish study that conclude there is a possible increased risk of miscarriage with the use of oral fluconazole (brand name Diflucan) for yeast infections.

Source: FDA Drug Safety Podcasts - May 3, 2016 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts